MedTrace Logo

ESD for the Treatment of Early Barrett's Neoplasia

NCT02583087 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-08-28

No results posted yet for this study

Summary

This study assesses the quality of the resection of early neoplasia arinsing in Barrett's esophagus using endoscopic submucosal dissection. It is a multicenter prospective registry among 7 centers including all consecutive patients with early Barrett's neoplasia of 15 mm or more in size treated by endoscopic submucosal dissection.

Conditions

  • Barrett Esophagus
  • Esophageal Neoplasm

Interventions

PROCEDURE

endoscopic submucosal dissection

Endoscopic resection of a superficial neoplastic lesion of the esophagus, including the mucosal and the submucosa resected en bloc.

Sponsors & Collaborators

  • French Society of Digestive Endoscopy

    collaborator OTHER

  • European Georges Pompidou Hospital

    collaborator OTHER

  • Hôpital Edouard Herriot

    collaborator OTHER

  • Hospital Prive Jean Mermoz

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • University Hospital, Bordeaux

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER

  • Hôpital Cochin

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2019-04-30
Completion
2022-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02583087 on ClinicalTrials.gov